S&P Lifts EssilorLuxottica Rating to A+ on Medtech Shift, Strong Cash Flow

06:52 AM EDT, 10/23/2026 (MT Newswires) -- S&P Global Ratings raised its long-term issuer credit rating on EssilorLuxottica (EL.PA) to A+ from A, with a stable outlook. The rating agency on Friday cited the ophthalmic lenses, frames, and sunglasses manufacturer's shift from a consumer-products business to a medtech player, with its prescription-based products acting as a "defensive buffer" against macroeconomic volatility, as well as its strong free operating cash flow. S&P forecasts EssilorLuxottica's revenue to increase 4.7% in 2026 and 7.5% annually in 2027 and 2028.